Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Judi Health

Judi Health IPO

$3.25B
Series F Valuation, Sep 2025
Register for details
For more details on financing and valuation for Judi Health, register or log in.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

Judi Health IPO date and status

2017
Founded
IPO Mentioned
Confidential Filing
S-1 Filed
IPO

Company details

Judi Health is a health technology company built around the mission of changing the way prescription drugs are priced and patients are serviced. Its Clearinghouse Model® is the first ethical framework for drug pricing. Capital Rx's enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem in one platform. This company was founded in 2017 and is headquartered in New York, NY.
Founded
2017
Headquarters
New York, NY, United States
Founders
Anthony Loiacono, Ryan Kelly
Forge Price 1
Price not yet available
Market Activity 2
Limited
Last Matched Price
Post-Money Valuation 3
$3.25B
Total Funding
$596.44MM
Last Funding Round
Series F

Learn more about Judi Health

To invest in Judi Health pre-IPO

Can you invest in Judi Health pre-IPO?

Judi Health is privately held and not traded on public markets, so pre-IPO investments are available only to accredited investors.

If you’re already accredited and have completed Forge’s verification, you can visit our marketplace to review and invest in private companies ahead of an IPO.

If you haven’t yet completed your accredited investor verification with Forge, you can start that process now to unlock access to new private-company offerings.

For more on who qualifies—and how to get verified—see our blog “Accredited investors, qualified clients and qualified purchasers: Who can invest?

Can you sell shares of Judi Health before it goes public?

Yes, subject to any contractual or corporate transfer restrictions, it is possible to list your shares to sell while Judi Health is still private. If you’re considering selling, you can register today for free to get started. Once registered, you can evaluate pricing insights and market activity to inform your decision, then post your shares for sale and set the terms, like quantity and price—all directly through our platform.

If you’d like additional guidance at any point, Forge private market specialists are available to help. For a step-by-step overview, check out our seller’s guide.

What is the pre-IPO value of my Judi Health shares?

To explore the value of your Judi Health shares, create a free account to access Forge’s marketplace. Once inside, you’ll find several pricing insights to help guide your decision—these include historical transaction data, a live order book showing current buy and sell interest, and Forge Price™, a derived, indicative price based on recent transactions, investor activity, and other relevant market data.

These insights can help you determine a price you’re comfortable with if you choose to sell your shares. If you’d like additional guidance along the way, Forge private market specialists are available to help. You can also review our seller’s guide for a step-by-step overview.

Is Judi Health a publicly traded company?

Judi Health is a private company and not publicly traded.

If you’re interested in buying or selling shares in private companies, you can register with Forge today for free to explore available opportunities. Once registered, you’ll gain access to our marketplace, where you can view active buy and sell interest, evaluate pricing signals and take action directly through the platform.

To learn more about Judi Health potential IPO

Will Judi Health go IPO?

Judi Health has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2025.

What is Judi Health’s IPO price?

The Judi Health IPO price does not exist at this time, as Judi Health is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Judi Health, register for Forge today.

When was Judi Health founded?

Judi Health was founded in 2017.

What is Judi Health funding to date?

Judi Health has raised $596.44MM to date.

Judi Health major investors

Alumni Ventures
B Capital Group
F-Prime Capital
General Catalyst
Transformation Capital

Judi Health pre-IPO valuation and funding rounds

Funding history chart
Funding round and deals details
Funding Date Round Amount Raised Price per Share Post-Money Valuation 3 Key Investors
09/23/2025 Series F $252.89MM $13.49 $3.25B 9yards Capital, B Capital, Edison Partners, General Catalyst, Generation Investment Management, Goldman Sachs, Prime Health Investments, Transformation Capital, Wellington Management
Price per Share
$ xx.xx
Shares Outstanding
18,743,617
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
9yards Capital, B Capital, Edison Partners, General Catalyst, Generation Investment Management, Goldman Sachs, Prime Health Investments, Transformation Capital, Wellington Management
03/28/2024 Series E $115MM $7.06 $1.57B Prime Therapeutics
Price per Share
$ xx.xx
Shares Outstanding
16,282,494
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Prime Therapeutics
08/11/2023 Series D $68MM $5.65 $1.02B Atlantic Health System, Banner Health, Hawai'i Pacific Health, Inova Health System, Lehigh Valley Health Network, Memorial Hermann Health System, Nebraska Medicine, Novant Health, Ochsner Health, Transformation Capital, Wellspan Health
Price per Share
$ xx.xx
Shares Outstanding
12,029,232
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Atlantic Health System, Banner Health, Hawai'i Pacific Health, Inova Health System, Lehigh Valley Health Network, Memorial Hermann Health System, Nebraska Medicine, Novant Health, Ochsner Health, Transformation Capital, Wellspan Health
06/13/2022 Series C $106MM $5.07 $850.03MM B Capital, Edison Partners, General Catalyst, Transformation Capital
Price per Share
$ xx.xx
Shares Outstanding
20,909,771
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital, Edison Partners, General Catalyst, Transformation Capital
02/02/2021 Series B $37.71MM $1.74 $251.49MM Edison Partners, Transformation Capital
Price per Share
$ xx.xx
Shares Outstanding
21,730,791
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Edison Partners, Transformation Capital
07/19/2019 Series A $13.95MM $0.77 $79.62MM Edison Partners, Emerald Development Managers
Price per Share
$ xx.xx
Shares Outstanding
18,215,524
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Edison Partners, Emerald Development Managers
03/01/2018 Series Seed $2.9MM $0.20 $15MM Undisclosed Investors
Price per Share
$ xx.xx
Shares Outstanding
14,500,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors

Judi Health IPO news and media highlights

Capital Rx nabs $50M backed by Inova, Ochsner and other health system investors

Ten health systems, including Banner Health and Memorial Herman, and digital health equity company Transformation Capital, have invested over $50 million in Capital Rx. This investment will support Capital Rx's cloud-native pharmacy benefits administrator and backend claims processing platform JUDI. The funds will be used for research and development, growth of member and client service teams, and key hiring areas within the company.

Capital Rx Closes on $50 Million from Transformation Capital and Others

New York-based Capital Rx, a pharmacy benefit manager and administrator, has secured over $50 million in a funding round led by Transformation Capital. Other participants included Inova Health System, Atlantic Health System, Banner Health, among others. The funds will be used to lower pharmacy costs, improve patient access, and deliver better outcomes. The firm's total funding now stands at $253 million.

Capital Rx CEO: PBM industry needs to be repaired, not ditched

The CEO of start-up Capital Rx, A.J. Loiacono, argues that the Pharmacy Benefit Managers (PBM) industry needs reform, not elimination. While acknowledging the issues with drug pricing, Loiacono maintains that PBMs perform crucial administrative functions in claims administration and patient management among others. Capital Rx recently became the first PBM serving Medicare, Medicaid, and employer-sponsored health plans to earn a B Corp Certification for social responsibility.
Browse More Insights

Private companies exploring an IPO

See which private companies are preparing for the public market. Register to get full access to the latest secondary market pricing data.

Sector: Healthcare
Subsector: Healthcare Providers & Services
Trade Metrics Last Funding Round
Company Forge Price Last Matched Round Post-Money Valuation 3 Price Per Share Amount Raised
VeraDermicsVeraDermicsNot available$ xx.xxSeries C$306.13MM$1.27$151MM
Eikon TherapeuticsEikon TherapeuticsNot available$ xx.xxSeries D$1.57B$5.84$326.93MM
Spyglass PharmaSpyglass PharmaNot available$ xx.xxSeries D$350.04MM$2.33$75MM
Affinia TherapeuticsAffinia TherapeuticsNot available$ xx.xxSeries C$156.61MM$1.62$40MM
OriginOriginNot available$ xx.xxNot available------

Private market movers

Track trading activity and investor momentum across thousands of private companies. Register to view last matched prices and additional transactional details.

Actively traded

Company Forge Price Market Activity Last Matched
SpaceX SpaceX $447.23 -$2.12 (0.47%)High $xxx.xx
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
Anduril Anduril $105.00 -$0.53 (0.50%)High $xxx.xx
Databricks Databricks $197.72 +$0.06 (0.03%)High $xxx.xx

Artificial Intelligence (AI)

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
Anduril Anduril $105.00 -$0.53 (0.50%)High $xxx.xx
Databricks Databricks $197.72 +$0.06 (0.03%)High $xxx.xx
Waymo Waymo Not availableLimited $xxx.xx

Forge, your trusted partner for pre-IPO insights and Capital Rx data

Forge is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Updated on: Jan 16, 2026

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions on Forge.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. Actively traded companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.